InvestSMART

HeraMED Limited (ASX: HMD) - Announcements

Current share price for HMD : $0.036 0.001 (2.86%)+

ASX company news and announcements for HeraMED Limited (HMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HeraMED Limited (HMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HeraMED Limited (HMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HeraMED Limited (HMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$42 LOI with Metronomic to develop postpartum care in US 26 Nov 2024 9:11AM $0.022 $0.036 risen by 63.64%
$42 Letter to Shareholders/Notice of General Meeting/Proxy Form 20 Nov 2024 1:10PM $0.021 $0.036 risen by 71.43%
$42 Proposed issue of securities - HMD 11 Nov 2024 11:23AM $0.023 $0.036 risen by 56.52%
$42 HeraMED completes further $1million placement 11 Nov 2024 9:51AM $0.021 $0.036 risen by 71.43%
$42 Application for quotation of securities - HMD 29 Oct 2024 3:21PM $0.022 $0.036 risen by 63.64%
$42 Cleansing Prospectus 29 Oct 2024 8:37AM $0.022 $0.036 risen by 63.64%
$42 Quarterly Activities & Cashflow Report 29 Oct 2024 8:10AM $0.022 $0.036 risen by 63.64%
$42 Proposed issue of securities - HMD 23 Oct 2024 10:54AM $0.019 $0.036 risen by 89.47%
$42 Proposed issue of securities - HMD 23 Oct 2024 10:17AM $0.025 $0.036 risen by 44%
$42 HeraMED completes $3.1 million placement 23 Oct 2024 10:17AM $0.025 $0.036 risen by 44%
$42 Trading Halt 21 Oct 2024 10:08AM $0.025 $0.036 risen by 44%
$42 Pause in Trading 21 Oct 2024 9:54AM $0.025 $0.036 risen by 44%
$42 HeraCARE user growth continues to rise 8 Oct 2024 10:17AM $0.020 $0.036 risen by 80%
$42 Notification of cessation of securities - HMD 4 Oct 2024 4:19PM $0.021 $0.036 risen by 71.43%
$42 HeraBEAT TGA regulatory classification to be upgraded 27 Sep 2024 11:56AM $0.018 $0.036 risen by 100%
$42 Letter of Intent with Founda Health 23 Sep 2024 9:33AM $0.021 $0.036 risen by 71.43%
$42 Appendix 4D and Half Year Report 28 Aug 2024 5:46PM $0.022 $0.036 risen by 63.64%
$42 Change of Registry Address 12 Aug 2024 4:32PM $0.014 $0.036 risen by 157.14%
$42 Quarterly Activities & Cashflow Report 30 Jul 2024 4:42PM $0.019 $0.036 risen by 89.47%
$42 Update to Managing Director & CEO Remuneration Package 23 Jul 2024 4:28PM $0.018 $0.036 risen by 100%
$42 UTS Strategic Partnership 15 Jul 2024 8:39AM $0.023 $0.036 risen by 56.52%
$42 Becoming a substantial holder 4 Jul 2024 9:43AM n/a $0.036 n/a
$42 Becoming a substantial holder 28 Jun 2024 11:59AM $0.023 $0.036 risen by 56.52%
$42 Change of Director's Interest Notice AG DH TC 28 Jun 2024 8:59AM $0.023 $0.036 risen by 56.52%
$42 Notification regarding unquoted securities - HMD 26 Jun 2024 1:49PM $0.025 $0.036 risen by 44%

101 - 125 of 537 results

Page 5 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.